Forms Processing

WHITE PAPERS AND CASE STUDIES

• Digital Endpoint Resource Guide: Obesity And Related Metabolic Disorders

  Explore how digital health technologies can enhance obesity treatment by providing critical insights beyond weight loss.

• Simplify CAPA In 7 Steps

  Discover how to streamline corrective action/preventive action (CAPA) management in regulatory environments in 7 steps.

• Revolutionizing Particle Characterization With Image Analysis And ML

  The biopharmaceutical industry is increasingly employing micro-flow imaging for particle characterization, owing to the superior insights it can afford into product quality and process controls.

• GSK And Medable Discuss The Next Phase Of DCTs

  GSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.

• Revolutionizing Lead Service Line Removal: A Milestone For Detroit's Water Infrastructure

  Detroit, like many other cities across the U.S., has grappled with a silent threat lurking within its aging water infrastructure: lead service lines. Learn why The Detroit Water and Sewage Department partnered with BlueConduit to help make the lead service line inventory and removal process more efficient than ever before.

• A Powerful Non-Destructive Tool For Tablet Characterization

  Discover how X-ray micro-CT provides vital, non-destructive analysis of a tablet’s internal 3D physical structure. This structural insight is essential for troubleshooting defects and confirming performance.

• The Untapped Power Of Real-World Data And AI In Pharma Commercialization

  Harnessing RWD in commercialization bridges the gap between approval and patient access, equipping companies with actionable intelligence to deliver life-changing therapies to more patients.

• Leveraging The Bolar Exemption To Accelerate Market Access

  Gain insight into the changing comparator sourcing landscape, focusing specifically on the instrumental role the Bolar exemption plays in the shift away from dependence on innovators for clinical supplies.

• Current Strategies For Enhancing Bioavailability

  Explore key strategies for enhancing bioavailability of poorly soluble drug compounds, including spray drying, particle size reduction, and lipid-based formulations supported by solid-state analysis.

• How A Pharma Company Improved Yield By 1.5% In Just Three Months

  A pharma company faced a 4% yield drop and variability at a manufacturing facility. Explore how they leveraged an AI-based platform to unify data, pinpoint inefficiencies, and enhance consistency in yields.

• The Future Is Now: CGT Innovation, Challenges, And Perspectives

  As CGTs advance toward clinical trials, developers face a number of challenges such as navigating a shifting regulatory landscape and employing beneficial manufacturing processes.

• Bringing In Vitro Diagnostics To Market With Real-World Evidence

  Explore the potential of real-world evidence in enhancing the regulatory decision-making process to facilitate the market entry of IVDs.